New process for managing orders for blood and blood products

01 August 2010

Last July, the Blood Service has implemented a new process for managing orders for blood components and fractionated products.

In doing so, we aim to deliver improved customer service through a more streamlined order approval process.

As a result, we have reviewed our order forms and made the following improvements:

  • There will now be four specific order forms reflecting the variety of products available.
    • The forms have been developed to allow prioritisation and prompt response to all orders.
  • For patient-specific orders, there are fields for supporting clinical information or laboratory results to be entered.

Timely provision of this information will assist with efficient order management and fewer follow-up telephone calls. The new order forms will be distributed in the next few weeks.

A transition period for full implementation of the new forms will occur across 2 months from 1 July 2010. Please ensure these changes are communicated to all relevant staff.

At this stage, there will be no changes to the current forms or processes for the ordering of intravenous immunoglobulin (IVIg).

In 6 months time, there will be a review of these forms and your input will be invited.

If you have any queries and comments in the meantime, please do not hesitate to contact Inventory and Distribution (I&D) or Transfusion Medicine Services (TMS) contacts at the Blood Service.

<< Back to iTransfuse express

Other articles

Australian Haemovigilance Report

The Blood Service introduces nucleic acid testing for HBV